Here's the live share price of Nath Bio-Genes (India) along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Nath Bio-Genes (India) has declined 9.98% CAGR. Over the past year, the corresponding return has been -12.76%.
Nath Bio-Genes (India)’s current P/E of 6.94x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Nath Bio-Genes (India) | 5.39 | 6.93 | -6.19 | -20.87 | -12.76 | 1.12 | -9.98 |
| Tierra Agrotech | -5.32 | 5.61 | 24.04 | 30.58 | -17.57 | -26.60 | -28.60 |
| Mangalam Seeds | 2.38 | -3.77 | -9.88 | -14.66 | -27.84 | 19.09 | 17.26 |
| Genesis IBRC India | 10.59 | -39.41 | 37.77 | 342.98 | 438.07 | 106.34 | 65.99 |
| Vivo Bio Tech | 16.12 | 4.63 | -16.10 | -13.02 | -14.94 | 2.30 | -9.34 |
| Shree Ganesh Bio-Tech (India) | -3.17 | -6.15 | -20.78 | -28.24 | -41.35 | -25.41 | -35.50 |
| Omega Ag-Seeds (Punjab) | -7.45 | -26.54 | -25.61 | -24.72 | -17.70 | 11.01 | 6.47 |
| Genomic Valley Biotech | -4.84 | -15.62 | -35.20 | -54.50 | -71.57 | 1.08 | 0 |
Over the last one year, Nath Bio-Genes (India) has declined 12.76% compared to peers like Tierra Agrotech (-17.57%), Mangalam Seeds (-27.84%), Genesis IBRC India (438.07%). From a 5 year perspective, Nath Bio-Genes (India) has underperformed peers relative to Tierra Agrotech (-28.60%) and Mangalam Seeds (17.26%).
| Day | SMA | EMA |
|---|---|---|
| 5 | 152.45 | 154.57 |
| 10 | 151.56 | 153.44 |
| 20 | 151.88 | 154.26 |
| 50 | 162.31 | 159.91 |
| 100 | 167.55 | 166.49 |
| 200 | 173.37 | 173.41 |
In the latest quarter, Nath Bio-Genes (India) remained same as its previous close in promoter holding, while DII stake decreased to 0.76%, FII holding fell to 0.32%, and public shareholding moved up to 53.31% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 1,26,341 | 0.03 | 2.08 |
* Excluding Index & Arbitrage Funds
Date Time | Announcement |
|---|---|
| Nov 18, 2025, 10:46 PM IST | Nath Bio-Genes - Announcement under Regulation 30 (LODR)-Earnings Call Transcript |
| Nov 14, 2025, 4:03 PM IST | Nath Bio-Genes - Announcement under Regulation 30 (LODR)-Investor Presentation |
| Nov 13, 2025, 11:38 PM IST | Nath Bio-Genes - Financial Results As On 30Th September 2025 |
| Nov 13, 2025, 11:35 PM IST | Nath Bio-Genes - Board Meeting Outcome for Outcome Of Board Meeting |
| Nov 10, 2025, 9:11 PM IST | Nath Bio-Genes - Intimation Of Earning Conference Call |
Nath Bio-Genes (India) Ltd. is a Public Limited Listed company incorporated on 14/07/1993 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L01110MH1993PLC072842 and registration number is 072842. Currently Company is involved in the business activities of Growing of non-perennial crops. Company's Total Operating Revenue is Rs. 362.31 Cr. and Equity Capital is Rs. 19.00 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Nath Bio-Genes (India) is ₹161.30 as on Dec 24, 2025.
The Nath Bio-Genes (India) is operating in the Agriculture / Horticulture / Lives Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Nath Bio-Genes (India) is ₹306.53 Cr as on Dec 24, 2025.
Today’s highest and lowest price of Nath Bio-Genes (India) are ₹162.80 and ₹160.20.
The 52-week high/low is the highest and lowest price at which Nath Bio-Genes (India) stock has traded in the past 52-week or nearly a year. The 52-week high of Nath Bio-Genes (India) is ₹238.00 and 52-week low of Nath Bio-Genes (India) is ₹140.10 as on Dec 24, 2025.
The Nath Bio-Genes (India) has shown returns of 1.38% over the past day, 6.93% for the past month, -6.19% over 3 months, -12.76% over 1 year, 1.12% across 3 years, and -9.98% over 5 years.
P/E ratio of and PB ratio of Nath Bio-Genes (India) are 6.94 and 0.45 on Dec 24, 2025. While the company gives a dividend yield of 1.24 per annum.